Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Randomized, Double-Blinded Study of an Antiemetic Pump, Using Benadryl®, Avitan® and Decadron® (BAD), for Children Receiving Moderately or Highly Emetogenic Chemotherapy

NCT00429702 is registered in ClinicalTrials.gov with University of South Florida as lead sponsor.

NCT NCT00429702
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00429702 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Randomized, Double-Blinded Study of an Antiemetic Pump, Using Benadryl®, Avitan® and Decadron® (BAD), for Children Receiving Moderately or Highly Emetogenic Chemotherapy
Lead sponsor
University of South Florida
Phase
Phase 2
Overall status
Terminated
Start date
October 31, 2007
Completion date
November 30, 2009
Enrollment
7 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

nausea, unspecified childhood solid tumor, protocol specific, vomiting